Smriti Banthia, MD
Clinical Cardiac Electrophysiology · Sarasota, FLNPI 1558544486
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (46.0%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 24 manufacturers reported payments, led by Medtronic at 56.7% of the total. Reporting peaked in 2023 at $13,617 and has fallen 73.1% since, to $3,663 in 2025. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in FL, where the typical reported total is $25,729.
Across 181 payments — averaging $142.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$15K
- Medical Device Business Services, Inc.$7K
- Abbott$1K
- Boston Scientific$890
- Biosense Webster, Inc.$426
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$381
- plus $1K from 18 others
Across 2 payments — averaging $5597.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$11K
What the payments were for
- Consulting fees$7,12528%
- Speaking & faculty fees$11,85046%
- Travel & lodging$7623%
- Food & beverage$6,03423%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 70 | $14,604 |
| Medical Device Business Services, Inc. | 4 | $7,125 |
| Abbott | 24 | $1,046 |
| Boston Scientific | 15 | $890 |
| Biosense Webster, Inc. | 9 | $426 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 16 | $381 |
| Acutus Medical, Inc. | 2 | $218 |
| Atricure, Inc. | 4 | $198 |
| Kestra Medical Technology Services, Inc. | 6 | $148 |
| Siemens Medical Solutions USA, Inc. | 1 | $146 |
| Philips North America LLC | 2 | $89 |
| Pfizer | 5 | $83 |
| Kiniksa Pharmaceuticals International, PLC | 2 | $62 |
| Cvrx, Inc. | 3 | $61 |
| Elutia, Inc. | 3 | $46 |
| Scpharmaceuticals Inc. | 2 | $41 |
| Sanofi-aventis U.S. LLC | 2 | $40 |
| Merck | 2 | $39 |
| E.r. Squibb & Sons, L.L.C. | 2 | $28 |
| Novartis | 2 | $28 |
| Boehringer Ingelheim | 2 | $27 |
| Biotronik Inc. | 1 | $18 |
| Impulse Dynamics (USA) Inc. | 1 | $17 |
| Cordis US CORP. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$25,771 in reported general payments places this provider in the 50th percentile of 249 clinical cardiac electrophysiology providers in Florida.
See all clinical cardiac electrophysiology providers in Florida →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 186 | $140,526 |
| XareltoRivaroxaban | 22 | $17,753 |
| MultaqDronedarone Hcl | 15 | $11,705 |
| Metoprolol Succinate | 73 | $1,113 |
| Amiodarone Hcl | 53 | $1,004 |
| Mupirocin | 98 | $641 |
| Dilt-XrDiltiazem Hcl | 11 | $456 |
| ClopidogrelClopidogrel Bisulfate | 35 | $435 |
| Mexiletine Hcl | 14 | $435 |
| Cephalexin | 100 | $432 |
| Flecainide Acetate | 15 | $325 |
| Pantoprazole Sodium | 47 | $246 |
| Metoprolol Tartrate | 33 | $194 |
| Ciprofloxacin Hcl | 14 | $87 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $83 | $140,526186 claims |
| Sanofi-aventis U.S. LLCMultaq | $40 | $11,70515 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 249 clinical cardiac electrophysiology providers in Florida.
Other clinical cardiac electrophysiology in Sarasota
- Brian BetenskySarasota$412K
- Antonio MorettaSarasota$312K
- Dilip MathewSarasota$209K
- Likhitesh JaikumarSarasota$63K
- Robert EckartSarasota$58K
- Usman SiddiquiWinter Park$1.2M
- Jose Osorio FilhoMiami$1.2M
- David KenigsbergFort Lauderdale$1M
- Raul WeissMiami Beach$887K
- Naushad ShaikKissimmee$691K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.